Evaluation of Cladribine treatment in refractory celiac disease type II

doi:10.3748/wjg.v17.i4.506

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 4

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5626)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

578

HTML

4633

Figures (1-3)

220

Tables (1-2)

195

Sum=5626

Jan 28, 2011 (publication date) through Dec 28, 2024

Times Cited of This Article

Times Cited (59)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jan 28, 2011; 17(4): 506-513
Published online Jan 28, 2011. doi: 10.3748/wjg.v17.i4.506

Full Size Figure Download Figure

Figure 2 Flowchart of the response to cladribine treatment. RCD: Refractory celiac disease; 2-CdA: 2-chlorodeoxyadenosine; auSCT: autologous hematopoietic stem cell transplantation; EATL: Enteropathy associated T-cell lymphoma.

Citation: Tack GJ, Verbeek WH, Al-Toma A, Kuik DJ, Schreurs MW, Visser O, Mulder CJ. Evaluation of Cladribine treatment in refractory celiac disease type II. World J Gastroenterol 2011; 17(4): 506-513
URL: https://www.wjgnet.com/1007-9327/full/v17/i4/506.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i4.506